Marinomed Biotech to cease operations as insolvency court orders business closure

Marinomed Biotech halted operations on Sept. 24, 2026 after the insolvency court ordered the business closed. The insolvency administrator filed the closure motion during a court hearing on Sept. 24. Asset sale process will begin under the administrator as the company moves toward liquidation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Marinomed Biotech AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2404696_en) on September 24, 2026, and is solely responsible for the information contained therein. (C)